119 related articles for article (PubMed ID: 19720094)
1. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
[TBL] [Abstract][Full Text] [Related]
2. Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents.
Ueda Y; Mori K; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2011 Jun; 409(4):663-8. PubMed ID: 21620801
[TBL] [Abstract][Full Text] [Related]
3. Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.
Sejima H; Mori K; Ariumi Y; Ikeda M; Kato N
Virus Res; 2012 Jul; 167(1):74-85. PubMed ID: 22579597
[TBL] [Abstract][Full Text] [Related]
4. [Replication of hepatitis C virus genome].
Kato N
Uirusu; 2008 Dec; 58(2):191-8. PubMed ID: 19374197
[TBL] [Abstract][Full Text] [Related]
5. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
Podevin P; Carpentier A; Pène V; Aoudjehane L; Carrière M; Zaïdi S; Hernandez C; Calle V; Méritet JF; Scatton O; Dreux M; Cosset FL; Wakita T; Bartenschlager R; Demignot S; Conti F; Rosenberg AR; Calmus Y
Gastroenterology; 2010 Oct; 139(4):1355-64. PubMed ID: 20600021
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
[TBL] [Abstract][Full Text] [Related]
8. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
10. Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.
Takeda M; Ikeda M; Ariumi Y; Wakita T; Kato N
J Gen Virol; 2012 Jul; 93(Pt 7):1422-1431. PubMed ID: 22456614
[TBL] [Abstract][Full Text] [Related]
11. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
Gottwein JM; Bukh J
Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
[TBL] [Abstract][Full Text] [Related]
12. Evaluation systems for anti-HCV drugs.
Moriishi K; Matsuura Y
Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275
[TBL] [Abstract][Full Text] [Related]
13. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.
Abe K; Ikeda M; Dansako H; Naka K; Kato N
Virus Res; 2007 Apr; 125(1):88-97. PubMed ID: 17239465
[TBL] [Abstract][Full Text] [Related]
14. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b.
Murakami K; Ishii K; Ishihara Y; Yoshizaki S; Tanaka K; Gotoh Y; Aizaki H; Kohara M; Yoshioka H; Mori Y; Manabe N; Shoji I; Sata T; Bartenschlager R; Matsuura Y; Miyamura T; Suzuki T
Virology; 2006 Aug; 351(2):381-92. PubMed ID: 16678876
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture.
Bartenschlager R
Curr Opin Microbiol; 2006 Aug; 9(4):416-22. PubMed ID: 16814596
[TBL] [Abstract][Full Text] [Related]
17. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR
Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750
[TBL] [Abstract][Full Text] [Related]
18. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
19. Cell culture and infection system for hepatitis C virus.
Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantitative measurement of luciferase reporter activity and cell number in two- and three-dimensional cultures of hepatitis C virus replicons.
Tonary AM; Pezacki JP
Anal Biochem; 2006 Mar; 350(2):239-48. PubMed ID: 16480942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]